Global Human Immune Globulin Intravenous Market Research Report 2020

Global Human Immune Globulin Intravenous Market Research Report 2020

Table of Contents
1 Human Immune Globulin Intravenous Market Overview
1.1 Product Overview and Scope of Human Immune Globulin Intravenous
1.2 Human Immune Globulin Intravenous Segment by Type
1.2.1 Global Human Immune Globulin Intravenous Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 IVIg Liquid
1.2.3 IVIg Powder
1.3 Human Immune Globulin Intravenous Segment by Application
1.3.1 Human Immune Globulin Intravenous Sales Comparison by Application: 2020 VS 2026
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Global Human Immune Globulin Intravenous Market Size Estimates and Forecasts
1.4.1 Global Human Immune Globulin Intravenous Revenue 2015-2026
1.4.2 Global Human Immune Globulin Intravenous Sales 2015-2026
1.4.3 Human Immune Globulin Intravenous Market Size by Region: 2020 Versus 2026
2 Global Human Immune Globulin Intravenous Market Competition by Manufacturers
2.1 Global Human Immune Globulin Intravenous Sales Market Share by Manufacturers (2015-2020)
2.2 Global Human Immune Globulin Intravenous Revenue Share by Manufacturers (2015-2020)
2.3 Global Human Immune Globulin Intravenous Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Human Immune Globulin Intravenous Manufacturing Sites, Area Served, Product Type
2.5 Human Immune Globulin Intravenous Market Competitive Situation and Trends
2.5.1 Human Immune Globulin Intravenous Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Human Immune Globulin Intravenous Players (Opinion Leaders)
3 Human Immune Globulin Intravenous Retrospective Market Scenario by Region
3.1 Global Human Immune Globulin Intravenous Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Human Immune Globulin Intravenous Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Human Immune Globulin Intravenous Market Facts & Figures by Country
3.3.1 North America Human Immune Globulin Intravenous Sales by Country
3.3.2 North America Human Immune Globulin Intravenous Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Human Immune Globulin Intravenous Market Facts & Figures by Country
3.4.1 Europe Human Immune Globulin Intravenous Sales by Country
3.4.2 Europe Human Immune Globulin Intravenous Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Human Immune Globulin Intravenous Market Facts & Figures by Region
3.5.1 Asia Pacific Human Immune Globulin Intravenous Sales by Region
3.5.2 Asia Pacific Human Immune Globulin Intravenous Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Human Immune Globulin Intravenous Market Facts & Figures by Country
3.6.1 Latin America Human Immune Globulin Intravenous Sales by Country
3.6.2 Latin America Human Immune Globulin Intravenous Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Human Immune Globulin Intravenous Market Facts & Figures by Country
3.7.1 Middle East and Africa Human Immune Globulin Intravenous Sales by Country
3.7.2 Middle East and Africa Human Immune Globulin Intravenous Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Human Immune Globulin Intravenous Historic Market Analysis by Type
4.1 Global Human Immune Globulin Intravenous Sales Market Share by Type (2015-2020)
4.2 Global Human Immune Globulin Intravenous Revenue Market Share by Type (2015-2020)
4.3 Global Human Immune Globulin Intravenous Price Market Share by Type (2015-2020)
4.4 Global Human Immune Globulin Intravenous Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Human Immune Globulin Intravenous Historic Market Analysis by Application
5.1 Global Human Immune Globulin Intravenous Sales Market Share by Application (2015-2020)
5.2 Global Human Immune Globulin Intravenous Revenue Market Share by Application (2015-2020)
5.3 Global Human Immune Globulin Intravenous Price by Application (2015-2020)
6 Company Profiles and Key Figures in Human Immune Globulin Intravenous Business
6.1 Baxter
6.1.1 Corporation Information
6.1.2 Baxter Description, Business Overview and Total Revenue
6.1.3 Baxter Human Immune Globulin Intravenous Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Baxter Products Offered
6.1.5 Baxter Recent Development
6.2 Grifols
6.2.1 Grifols Human Immune Globulin Intravenous Production Sites and Area Served
6.2.2 Grifols Description, Business Overview and Total Revenue
6.2.3 Grifols Human Immune Globulin Intravenous Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Grifols Products Offered
6.2.5 Grifols Recent Development
6.3 CSL
6.3.1 CSL Human Immune Globulin Intravenous Production Sites and Area Served
6.3.2 CSL Description, Business Overview and Total Revenue
6.3.3 CSL Human Immune Globulin Intravenous Sales, Revenue and Gross Margin (2015-2020)
6.3.4 CSL Products Offered
6.3.5 CSL Recent Development
6.4 Octapharma
6.4.1 Octapharma Human Immune Globulin Intravenous Production Sites and Area Served
6.4.2 Octapharma Description, Business Overview and Total Revenue
6.4.3 Octapharma Human Immune Globulin Intravenous Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Octapharma Products Offered
6.4.5 Octapharma Recent Development
6.5 Biotest
6.5.1 Biotest Human Immune Globulin Intravenous Production Sites and Area Served
6.5.2 Biotest Description, Business Overview and Total Revenue
6.5.3 Biotest Human Immune Globulin Intravenous Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Biotest Products Offered
6.5.5 Biotest Recent Development
6.6 Kedrion
6.6.1 Kedrion Human Immune Globulin Intravenous Production Sites and Area Served
6.6.2 Kedrion Description, Business Overview and Total Revenue
6.6.3 Kedrion Human Immune Globulin Intravenous Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Kedrion Products Offered
6.6.5 Kedrion Recent Development
6.7 Hualan Bio
6.6.1 Hualan Bio Human Immune Globulin Intravenous Production Sites and Area Served
6.6.2 Hualan Bio Description, Business Overview and Total Revenue
6.6.3 Hualan Bio Human Immune Globulin Intravenous Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Hualan Bio Products Offered
6.7.5 Hualan Bio Recent Development
6.8 CNBG
6.8.1 CNBG Human Immune Globulin Intravenous Production Sites and Area Served
6.8.2 CNBG Description, Business Overview and Total Revenue
6.8.3 CNBG Human Immune Globulin Intravenous Sales, Revenue and Gross Margin (2015-2020)
6.8.4 CNBG Products Offered
6.8.5 CNBG Recent Development
6.9 Shanghai RAAS
6.9.1 Shanghai RAAS Human Immune Globulin Intravenous Production Sites and Area Served
6.9.2 Shanghai RAAS Description, Business Overview and Total Revenue
6.9.3 Shanghai RAAS Human Immune Globulin Intravenous Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Shanghai RAAS Products Offered
6.9.5 Shanghai RAAS Recent Development
6.10 CBPO
6.10.1 CBPO Human Immune Globulin Intravenous Production Sites and Area Served
6.10.2 CBPO Description, Business Overview and Total Revenue
6.10.3 CBPO Human Immune Globulin Intravenous Sales, Revenue and Gross Margin (2015-2020)
6.10.4 CBPO Products Offered
6.10.5 CBPO Recent Development
6.11 LFB Group
6.11.1 LFB Group Human Immune Globulin Intravenous Production Sites and Area Served
6.11.2 LFB Group Human Immune Globulin Intravenous Description, Business Overview and Total Revenue
6.11.3 LFB Group Human Immune Globulin Intravenous Sales, Revenue and Gross Margin (2015-2020)
6.11.4 LFB Group Products Offered
6.11.5 LFB Group Recent Development
6.12 BPL
6.12.1 BPL Human Immune Globulin Intravenous Production Sites and Area Served
6.12.2 BPL Human Immune Globulin Intravenous Description, Business Overview and Total Revenue
6.12.3 BPL Human Immune Globulin Intravenous Sales, Revenue and Gross Margin (2015-2020)
6.12.4 BPL Products Offered
6.12.5 BPL Recent Development
6.13 Sichuan Yuanda Shuyang
6.13.1 Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Production Sites and Area Served
6.13.2 Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Description, Business Overview and Total Revenue
6.13.3 Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Sichuan Yuanda Shuyang Products Offered
6.13.5 Sichuan Yuanda Shuyang Recent Development
7 Human Immune Globulin Intravenous Manufacturing Cost Analysis
7.1 Human Immune Globulin Intravenous Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Human Immune Globulin Intravenous
7.4 Human Immune Globulin Intravenous Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Human Immune Globulin Intravenous Distributors List
8.3 Human Immune Globulin Intravenous Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Human Immune Globulin Intravenous Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Human Immune Globulin Intravenous by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Human Immune Globulin Intravenous by Type (2021-2026)
10.2 Human Immune Globulin Intravenous Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Human Immune Globulin Intravenous by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Human Immune Globulin Intravenous by Application (2021-2026)
10.3 Human Immune Globulin Intravenous Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Human Immune Globulin Intravenous by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Human Immune Globulin Intravenous by Region (2021-2026)
10.4 North America Human Immune Globulin Intravenous Estimates and Projections (2021-2026)
10.5 Europe Human Immune Globulin Intravenous Estimates and Projections (2021-2026)
10.6 Asia Pacific Human Immune Globulin Intravenous Estimates and Projections (2021-2026)
10.7 Latin America Human Immune Globulin Intravenous Estimates and Projections (2021-2026)
10.8 Middle East and Africa Human Immune Globulin Intravenous Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Human Immune Globulin Intravenous Sales (MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Human Immune Globulin Intravenous Sales (MT) Comparison by Application: 2020 VS 2026
Table 3. Global Human Immune Globulin Intravenous Market Size by Type (MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Human Immune Globulin Intravenous Manufacturers Covered in This Study
Table 5. Global Human Immune Globulin Intravenous Sales (MT) by Manufacturers (2015-2020)
Table 6. Global Human Immune Globulin Intravenous Sales Share by Manufacturers (2015-2020)
Table 7. Global Human Immune Globulin Intravenous Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Human Immune Globulin Intravenous Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Human Immune Globulin Intravenous Average Price (USD/Kg) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Human Immune Globulin Intravenous Sales Sites and Area Served
Table 11. Manufacturers Human Immune Globulin Intravenous Product Types
Table 12. Global Human Immune Globulin Intravenous Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Human Immune Globulin Intravenous by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Immune Globulin Intravenous as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Human Immune Globulin Intravenous Players
Table 16. Global Human Immune Globulin Intravenous Sales (MT) by Region (2015-2020)
Table 17. Global Human Immune Globulin Intravenous Sales Market Share by Region (2015-2020)
Table 18. Global Human Immune Globulin Intravenous Revenue (Million US$) by Region (2015-2020)
Table 19. Global Human Immune Globulin Intravenous Revenue Market Share by Region (2015-2020)
Table 20. North America Human Immune Globulin Intravenous Sales by Country (2015-2020) (MT)
Table 21. North America Human Immune Globulin Intravenous Sales Market Share by Country (2015-2020)
Table 22. North America Human Immune Globulin Intravenous Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Human Immune Globulin Intravenous Revenue Market Share by Country (2015-2020)
Table 24. Europe Human Immune Globulin Intravenous Sales by Country (2015-2020) (MT)
Table 25. Europe Human Immune Globulin Intravenous Sales Market Share by Country (2015-2020)
Table 26. Europe Human Immune Globulin Intravenous Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Human Immune Globulin Intravenous Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Human Immune Globulin Intravenous Sales by Region (2015-2020) (MT)
Table 29. Asia Pacific Human Immune Globulin Intravenous Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Human Immune Globulin Intravenous Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Human Immune Globulin Intravenous Revenue Market Share by Region (2015-2020)
Table 32. Latin America Human Immune Globulin Intravenous Sales by Country (2015-2020) (MT)
Table 33. Latin America Human Immune Globulin Intravenous Sales Market Share by Country (2015-2020)
Table 34. Latin America Human Immune Globulin Intravenous Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Human Immune Globulin Intravenous Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Human Immune Globulin Intravenous Sales by Country (2015-2020) (MT)
Table 37. Middle East and Africa Human Immune Globulin Intravenous Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Human Immune Globulin Intravenous Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Human Immune Globulin Intravenous Revenue Market Share by Country (2015-2020)
Table 40. Global Human Immune Globulin Intravenous Sales (MT) by Type (2015-2020)
Table 41. Global Human Immune Globulin Intravenous Sales Share by Type (2015-2020)
Table 42. Global Human Immune Globulin Intravenous Revenue (Million US$) by Type (2015-2020)
Table 43. Global Human Immune Globulin Intravenous Revenue Share by Type (2015-2020)
Table 44. Global Human Immune Globulin Intravenous Price (USD/Kg) by Type (2015-2020)
Table 45. Global Human Immune Globulin Intravenous Sales (MT) by Application (2015-2020)
Table 46. Global Human Immune Globulin Intravenous Sales Market Share by Application (2015-2020)
Table 47. Global Human Immune Globulin Intravenous Sales Growth Rate by Application (2015-2020)
Table 48. Baxter Human Immune Globulin Intravenous Corporation Information
Table 49. Baxter Description and Business Overview
Table 50. Baxter Human Immune Globulin Intravenous Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 51. Baxter Main Product
Table 52. Baxter Recent Development
Table 53. Grifols Human Immune Globulin Intravenous Corporation Information
Table 54. Grifols Corporation Information
Table 55. Grifols Human Immune Globulin Intravenous Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 56. Grifols Main Product
Table 57. Grifols Recent Development
Table 58. CSL Human Immune Globulin Intravenous Corporation Information
Table 59. CSL Corporation Information
Table 60. CSL Human Immune Globulin Intravenous Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 61. CSL Main Product
Table 62. CSL Recent Development
Table 63. Octapharma Human Immune Globulin Intravenous Corporation Information
Table 64. Octapharma Corporation Information
Table 65. Octapharma Human Immune Globulin Intravenous Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 66. Octapharma Main Product
Table 67. Octapharma Recent Development
Table 68. Biotest Human Immune Globulin Intravenous Corporation Information
Table 69. Biotest Corporation Information
Table 70. Biotest Human Immune Globulin Intravenous Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 71. Biotest Main Product
Table 72. Biotest Recent Development
Table 73. Kedrion Human Immune Globulin Intravenous Corporation Information
Table 74. Kedrion Corporation Information
Table 75. Kedrion Human Immune Globulin Intravenous Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 76. Kedrion Main Product
Table 77. Kedrion Recent Development
Table 78. Hualan Bio Human Immune Globulin Intravenous Corporation Information
Table 79. Hualan Bio Corporation Information
Table 80. Hualan Bio Human Immune Globulin Intravenous Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 81. Hualan Bio Main Product
Table 82. Hualan Bio Recent Development
Table 83. CNBG Human Immune Globulin Intravenous Corporation Information
Table 84. CNBG Corporation Information
Table 85. CNBG Human Immune Globulin Intravenous Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 86. CNBG Main Product
Table 87. CNBG Recent Development
Table 88. Shanghai RAAS Human Immune Globulin Intravenous Corporation Information
Table 89. Shanghai RAAS Corporation Information
Table 90. Shanghai RAAS Human Immune Globulin Intravenous Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 91. Shanghai RAAS Main Product
Table 92. Shanghai RAAS Recent Development
Table 93. CBPO Human Immune Globulin Intravenous Corporation Information
Table 94. CBPO Corporation Information
Table 95. CBPO Human Immune Globulin Intravenous Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 96. CBPO Main Product
Table 97. CBPO Recent Development
Table 98. LFB Group Human Immune Globulin Intravenous Corporation Information
Table 99. LFB Group Corporation Information
Table 100. LFB Group Human Immune Globulin Intravenous Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 101. LFB Group Main Product
Table 102. LFB Group Recent Development
Table 103. BPL Human Immune Globulin Intravenous Corporation Information
Table 104. BPL Corporation Information
Table 105. BPL Human Immune Globulin Intravenous Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 106. BPL Main Product
Table 107. BPL Recent Development
Table 108. Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Corporation Information
Table 109. Sichuan Yuanda Shuyang Corporation Information
Table 110. Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 111. Sichuan Yuanda Shuyang Main Product
Table 112. Sichuan Yuanda Shuyang Recent Development
Table 113. Sales Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Human Immune Globulin Intravenous Distributors List
Table 116. Human Immune Globulin Intravenous Customers List
Table 117. Market Key Trends
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Global Human Immune Globulin Intravenous Sales (MT) Forecast by Type (2021-2026)
Table 121. Global Human Immune Globulin Intravenous Sales Market Share Forecast by Type (2021-2026)
Table 122. Global Human Immune Globulin Intravenous Revenue (Million US$) Forecast by Type (2021-2026)
Table 123. Global Human Immune Globulin Intravenous Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 124. Global Human Immune Globulin Intravenous Sales (MT) Forecast by Application (2021-2026)
Table 125. Global Human Immune Globulin Intravenous Revenue (Million US$) Forecast by Application (2021-2026)
Table 126. Global Human Immune Globulin Intravenous Sales (MT) Forecast by Region (2021-2026)
Table 127. Global Human Immune Globulin Intravenous Sales Market Share Forecast by Region (2021-2026)
Table 128. Global Human Immune Globulin Intravenous Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Global Human Immune Globulin Intravenous Revenue Market Share Forecast by Region (2021-2026)
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Human Immune Globulin Intravenous
Figure 2. Global Human Immune Globulin Intravenous Sales Market Share by Type: 2020 VS 2026
Figure 3. IVIg Liquid Product Picture
Figure 4. IVIg Powder Product Picture
Figure 5. Global Human Immune Globulin Intravenous Consumption Market Share by Application: 2020 VS 2026
Figure 6. Immunodeficiency
Figure 7. Autoimmune Disease
Figure 8. Acute Infection
Figure 9. Global Human Immune Globulin Intravenous Market Size 2015-2026 (US$ Million)
Figure 10. Global Human Immune Globulin Intravenous Sales Capacity (MT) (2015-2026)
Figure 11. Global Human Immune Globulin Intravenous Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Human Immune Globulin Intravenous Sales Share by Manufacturers in 2020
Figure 13. Global Human Immune Globulin Intravenous Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Human Immune Globulin Intravenous Revenue in 2019
Figure 15. Human Immune Globulin Intravenous Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Human Immune Globulin Intravenous Sales Market Share by Region (2015-2020)
Figure 17. Global Human Immune Globulin Intravenous Sales Market Share by Region in 2019
Figure 18. Global Human Immune Globulin Intravenous Revenue Market Share by Region (2015-2020)
Figure 19. Global Human Immune Globulin Intravenous Revenue Market Share by Region in 2019
Figure 20. North America Human Immune Globulin Intravenous Sales Market Share by Country in 2019
Figure 21. North America Human Immune Globulin Intravenous Revenue Market Share by Country in 2019
Figure 22. U.S. Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT)
Figure 23. U.S. Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT)
Figure 25. Canada Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Human Immune Globulin Intravenous Sales Market Share by Country in 2019
Figure 27. Europe Human Immune Globulin Intravenous Revenue Market Share by Country in 2019
Figure 28. Germany Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT)
Figure 29. Germany Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT)
Figure 31. France Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT)
Figure 33. U.K. Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT)
Figure 35. Italy Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT)
Figure 37. Russia Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Human Immune Globulin Intravenous Sales Market Share by Region in 2019
Figure 39. Asia Pacific Human Immune Globulin Intravenous Revenue Market Share by Region in 2019
Figure 40. China Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT)
Figure 41. China Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT)
Figure 43. Japan Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT)
Figure 45. South Korea Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT)
Figure 47. India Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT)
Figure 49. Australia Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT)
Figure 51. Taiwan Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT)
Figure 53. Indonesia Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT)
Figure 55. Thailand Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT)
Figure 57. Malaysia Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT)
Figure 59. Philippines Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT)
Figure 61. Vietnam Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Human Immune Globulin Intravenous Sales Market Share by Country in 2019
Figure 63. Latin America Human Immune Globulin Intravenous Revenue Market Share by Country in 2019
Figure 64. Mexico Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT)
Figure 65. Mexico Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT)
Figure 67. Brazil Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT)
Figure 69. Argentina Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Human Immune Globulin Intravenous Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Human Immune Globulin Intravenous Revenue Market Share by Country in 2019
Figure 72. Turkey Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT)
Figure 73. Turkey Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT)
Figure 75. Saudi Arabia Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. U.A.E Human Immune Globulin Intravenous Sales Growth Rate (2015-2020) (MT)
Figure 77. U.A.E Human Immune Globulin Intravenous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Human Immune Globulin Intravenous by Type (2015-2020)
Figure 79. Sales Market Share of Human Immune Globulin Intravenous by Type in 2019
Figure 80. Revenue Share of Human Immune Globulin Intravenous by Type (2015-2020)
Figure 81. Revenue Market Share of Human Immune Globulin Intravenous by Type in 2019
Figure 82. Global Human Immune Globulin Intravenous Sales Growth by Type (2015-2020) (MT)
Figure 83. Global Human Immune Globulin Intravenous Sales Market Share by Application (2015-2020)
Figure 84. Global Human Immune Globulin Intravenous Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of Human Immune Globulin Intravenous by Application (2015-2020)
Figure 86. Global Revenue Share of Human Immune Globulin Intravenous by Application in 2020
Figure 87. Baxter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Grifols Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. CSL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Octapharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Biotest Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Kedrion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Hualan Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. CNBG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Shanghai RAAS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. CBPO Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. LFB Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. BPL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Sichuan Yuanda Shuyang Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Price Trend of Key Raw Materials
Figure 101. Manufacturing Cost Structure of Human Immune Globulin Intravenous
Figure 102. Manufacturing Process Analysis of Human Immune Globulin Intravenous
Figure 103. Human Immune Globulin Intravenous Industrial Chain Analysis
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Figure 106. Porter's Five Forces Analysis
Figure 107. North America Human Immune Globulin Intravenous Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 108. North America Human Immune Globulin Intravenous Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Europe Human Immune Globulin Intravenous Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 110. Europe Human Immune Globulin Intravenous Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Latin America Human Immune Globulin Intravenous Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 112. Latin America Human Immune Globulin Intravenous Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Middle East and Africa Human Immune Globulin Intravenous Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 114. Middle East and Africa Human Immune Globulin Intravenous Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Asia Pacific Human Immune Globulin Intravenous Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 116. Asia Pacific Human Immune Globulin Intravenous Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 117. Bottom-up and Top-down Approaches for This Report
Figure 118. Data Triangulation
Figure 119. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Dextran - Global Market Insights and Sales Trends 2024 -2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 122

The global Dextran market was valued at US$ 234.14 million in 2022 and it will reach US$ 346.64 million by the end of 2029, growing at a CAGR of 5.97% during 2023-2029. Report Scope This report aims to provide a comprehensive presentation of the global market for Dextran, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed bu......

Global Corticosteroids API Market Research Report 2023

Published: 11-Jan-2024        Price: US 2900 Onwards        Pages: 162

The global Corticosteroids API market was valued at US$ 2206.26 million in 2022 and is anticipated to reach US$ 3309.40 million by 2029, witnessing a CAGR of 6.11% during the forecast period 2023-2029. North American market for Corticosteroids API is estimated to increase from $ 220.53 million in 2022 to reach $ 302.18 million by 2029, at a CAGR of 4.69 % during the forecast period of 2023 through 2029. Europe market for Corticosteroids API is estimated to increase from $ 512.79 mi......

Global HPLC Columns Market Research Report 2023

Published: 11-Jan-2024        Price: US 2900 Onwards        Pages: 149

The global HPLC Columns market was valued at US$ 1823.16 million in 2022 and is anticipated to reach US$ 2674.78 million by 2029, witnessing a CAGR of 6.37% during the forecast period 2023-2029. The major global manufacturers of HPLC Columns include Agilent, Waters Corporation, Shimadzu, Thermo Fisher Scientific, Danaher, Hamilton, Merck, Bio - Rad, and Restek, etc. In 2022, the world's top three vendors accounted for approximately 48.41 % of the revenue. Report Scope This r......

Global Inorganic Advanced Phase Change Materials Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Inorganic Advanced Phase Change Materials market was valued at US$ 960.3 million in 2023 and is anticipated to reach US$ 2087.3 million by 2030, witnessing a CAGR of 11.9% during The forecast period 2024-2030. North American market for Inorganic Advanced Phase Change Materials is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Inorganic Advanced Phase Ch......

Global Material Jetting 3D Printing Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 88

The global Material Jetting 3D Printing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Material Jetting 3D Printing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Material Jetting 3D Printing is estimated to increase from $ million i......

Global Halogen Free Material Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 81

The global Halogen Free Material market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Halogen Free Material is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Halogen Free Material is estimated to increase from $ million in 2023 to reach $ mil......

Global Silicone Adhesives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 101

The global Silicone Adhesives market was valued at US$ 1999.8 million in 2023 and is anticipated to reach US$ 2628.8 million by 2030, witnessing a CAGR of 3.5% during The forecast period 2024-2030. North American market for Silicone Adhesives is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Silicone Adhesives is estimated to increase from $ million in 2023 to rea......

Global Paraffin Hydrotreating Catalyst Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 91

The global Paraffin Hydrotreating Catalyst market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Paraffin Hydrotreating Catalyst is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Paraffin Hydrotreating Catalyst is estimated to increase from $ ......

Global Stained Glass Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Stained Glass market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Stained Glass is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Stained Glass is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs